UPClytics
EnglishDeutsch
Sign inSign up
View all cases

ORD 22456/2025

—·EP4201327: FLUID DELIVERY DEVICE WITH TRANSCUTANEOUS ACCESS TOOL, INSERTION MECHANISM AND BLOOD GLUCOSE MONITORING FOR USE THEREWITH

Case details
Status
—
Action
Default judgment
Category
Default Judgments
Parties
Claimants
Reps: Frank Peterreins (Peterreins Schley)
Respondents
Reps: Christopher Pierce (Hoyng Rokh Monegier)
Division
Milan CD
Judges
Technology
Packaging & Conveying
Language
—
First decided
May 28, 2025
Claims
At issueall
Maintainedall
Infringedall
Notes: Milan Central Division (same decision as CC_65201/2024) found EOFLOW infringed EP 4 201 327; revocation action dismissed; patent maintained; no specific claim numbers enumerated in excerpt.
Decisions
  • 2025-05-28
    InfringedInjunction grantedDefault judgmentDecision By Default

    Decision by Milan Central Division (UPC_CFI_597/2024, 22 July 2025) on EOFLOW's revocation action and Insulet's counterclaim for infringement of EP 4 201 327 (wearable insulin pump / patch pump). The court rejected EOFLOW's revocation action (patent upheld as valid) and found EOFLOW's EOPatch product infringed the patent. The court ordered an injunction across 16 UPC member states, product recall, removal from distribution channels, destruction, and full information obligations. The decision also addressed the decision-by-default procedure, patent lexicon interpretation, and the cap on recoverable costs in parallel proceedings.

    Legal issues:Revocation action (patent maintained)Infringement (found)Decision by default (R. 355.2 RoP)Claim interpretation / patent lexiconInjunction, recall and destructionCosts cap in double litigation (Art. 1(3) Admin Committee decision)
    Damages: Liability declared, amount deferred
Documents
  • 94C54ABAB44EA845CCDECAF6E1B90AFF_en.pdf2025-05-28EN